Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May 12;48(3):E151-E152.
doi: 10.1503/jpn.230022-l. Print 2023 May-Jun.

Consistent terminology for medication-related problems in pharmacogenomic cases

Thomas M Polasek  1 , Sam Mostafa  1 , Carl M J Kirkpatrick  1
Affiliations
Comment

Consistent terminology for medication-related problems in pharmacogenomic cases

Thomas M Polasek et al. J Psychiatry Neurosci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Thomas Polasek provides a pharmacogenomics consulting service for Sonic Healthcare Ltd., and Sam Mostafa is employed by myDNA Life, a company offering pharmacogenomic testing and advice. No other competing interests were declared.

Comment in

Comment on

References

    1. Korchia T, Joober R, Richieri R, et al. . Utilizing pharmacogenetics when treating first episode psychosis. J Psychiatry Neurosci 2023;48:E11–2. - PMC - PubMed
    1. Brockmoller J, Kirchheiner J, Schmider J, et al. . The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Clin Pharmacol Ther 2002;72:438–52. - PubMed
    1. Zhang L, Brown SJ, Shan Y, et al. . CYP2D6 genetic polymorphisms and risperidone pharmacokinetics: a systematic review and meta-analysis. Pharmacotherapy 2020;40:632–47. - PubMed
    1. Zhang X, Xiang Q, Zhao X, et al. . Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: a systematic review and meta-analysis. J Clin Pharm Ther 2019;44:163–73. - PubMed
    1. Vermeir M, Naessens I, Remmerie B, et al. . Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans. Drug Metab Dispos 2008;36:769–79. - PubMed